(2R,3R,4R,5R)-2,5-Bis-((E)-3-bromo-allyloxy)-6-[N'-(4-tert-butyl-benzoyl)-hydrazino]-3,4-dihydroxy-6-oxo-hexanoic acid ((1S,2R)-2-hydroxy-indan-1-yl)-amide | 866755-70-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 茚满类
• 英文名称: (2R,3R,4R,5R)-2,5-Bis-((E)-3-bromo-allyloxy)-6-[N'-(4-tert-butyl-benzoyl)-hydrazino]-3,4-dihydroxy-6-oxo-hexanoic acid ((1S,2R)-2-hydroxy-indan-1-yl)-amide
• 英文别名: (2R,3R,4R,5R)-2,5-bis[(E)-3-bromoprop-2-enoxy]-6-[2-(4-tert-butylbenzoyl)hydrazinyl]-3,4-dihydroxy-N-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-6-oxohexanamide
• CAS: 866755-70-6
• 化学式: C₃₂H₃₉Br₂N₃O₈
• 分子量: 753.485
• InChiKey: QGSYHABIFFECIP-WXMBWODASA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.8
• 重原子数：
  45
• 可旋转键数：
  14
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.41
• 拓扑面积：
  166
• 氢给体数：
  6
• 氢受体数：
  8

反应信息

• 作为反应物：
  描述：

  (2R,3R,4R,5R)-2,5-Bis-((E)-3-bromo-allyloxy)-6-[N'-(4-tert-butyl-benzoyl)-hydrazino]-3,4-dihydroxy-6-oxo-hexanoic acid ((1S,2R)-2-hydroxy-indan-1-yl)-amide 在 伯吉斯试剂 、 三乙胺 作用下， 以 四氢呋喃 、 二氯甲烷 为溶剂， 生成 (2R,3S,4S,5R)-2,5-Bis-((E)-3-bromo-allyloxy)-5-[5-(4-tert-butyl-phenyl)-[1,3,4]oxadiazol-2-yl]-3,4-bis-trimethylsilanyloxy-pentanoic acid ((1S,2R)-2-trimethylsilanyloxy-indan-1-yl)-amide
  参考文献：
  名称：

  Synthesis of Malarial Plasmepsin Inhibitors and Prediction of Binding Modes by Molecular Dynamics Simulations

  摘要：

  A series of inhibitors of the malarial aspartic proteases Plm I and II have been synthesized with L-mannitol as precursor. These inhibitors are characterized by either a diacylhydrazine or a five-membered oxadiazole ring replacing backbone amide functionalities. Molecular dynamics simulations were applied in the design process. The computationally predicted Plm II K-i values were generally in excellent agreement with the biological results. The diacylhydrazine was found to be superior over the oxadiazole as an amide bond replacement in the Plm I and II inhibitors studied. An extensive flexibility of the S2 ' pocket was captured by the simulations predicting the binding mode of the unsymmetrical inhibitors. Plm I and II inhibitors with single digit nanomolar K-i values devoid of inhibitory activity toward human Cat D were identified. One compound, lacking amide bonds, was found to be Plm IV selective and very potent, with a K-i value of 35 nM.

  DOI：

  10.1021/jm050463l
• 作为产物：
  描述：

  (1S,2R)-(-)-1-氨基-2-茚醇 在 2-羟基吡啶 作用下， 以 二氯甲烷 为溶剂， 反应 15.0h， 生成 (2R,3R,4R,5R)-2,5-Bis-((E)-3-bromo-allyloxy)-6-[N'-(4-tert-butyl-benzoyl)-hydrazino]-3,4-dihydroxy-6-oxo-hexanoic acid ((1S,2R)-2-hydroxy-indan-1-yl)-amide
  参考文献：
  名称：

  Synthesis of Malarial Plasmepsin Inhibitors and Prediction of Binding Modes by Molecular Dynamics Simulations

  摘要：

  A series of inhibitors of the malarial aspartic proteases Plm I and II have been synthesized with L-mannitol as precursor. These inhibitors are characterized by either a diacylhydrazine or a five-membered oxadiazole ring replacing backbone amide functionalities. Molecular dynamics simulations were applied in the design process. The computationally predicted Plm II K-i values were generally in excellent agreement with the biological results. The diacylhydrazine was found to be superior over the oxadiazole as an amide bond replacement in the Plm I and II inhibitors studied. An extensive flexibility of the S2 ' pocket was captured by the simulations predicting the binding mode of the unsymmetrical inhibitors. Plm I and II inhibitors with single digit nanomolar K-i values devoid of inhibitory activity toward human Cat D were identified. One compound, lacking amide bonds, was found to be Plm IV selective and very potent, with a K-i value of 35 nM.

  DOI：

  10.1021/jm050463l

文献信息

• Synthesis of Malarial Plasmepsin Inhibitors and Prediction of Binding Modes by Molecular Dynamics Simulations
  作者：Karolina Ersmark、Martin Nervall、Elizabeth Hamelink、Linda K. Janka、Jose C. Clemente、Ben M. Dunn、Michael J. Blackman、Bertil Samuelsson、Johan Åqvist、Anders Hallberg

  DOI：10.1021/jm050463l

  日期：2005.9.1

  A series of inhibitors of the malarial aspartic proteases Plm I and II have been synthesized with L-mannitol as precursor. These inhibitors are characterized by either a diacylhydrazine or a five-membered oxadiazole ring replacing backbone amide functionalities. Molecular dynamics simulations were applied in the design process. The computationally predicted Plm II K-i values were generally in excellent agreement with the biological results. The diacylhydrazine was found to be superior over the oxadiazole as an amide bond replacement in the Plm I and II inhibitors studied. An extensive flexibility of the S2 ' pocket was captured by the simulations predicting the binding mode of the unsymmetrical inhibitors. Plm I and II inhibitors with single digit nanomolar K-i values devoid of inhibitory activity toward human Cat D were identified. One compound, lacking amide bonds, was found to be Plm IV selective and very potent, with a K-i value of 35 nM.